DaBomb Protein Biotech Corp. (TPEX:6578)
Taiwan
· Delayed Price · Currency is TWD 15.75
+0.05 (0.32%)
Apr 29, 2026, 1:30 PM CST
DaBomb Protein Biotech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -69.34 | 11.64 | -57.03 | -44.66 | -62.45 | Upgrade
|
| Depreciation & Amortization | 41 | 13.65 | 21.62 | 26.74 | 25.99 | Upgrade
|
| Other Amortization | 0.02 | 0.06 | 0.1 | 0.25 | 0.25 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.16 | -0.04 | 25.59 | -0.05 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 40.65 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 0.02 | 0.07 | -0.14 | 0.04 | Upgrade
|
| Stock-Based Compensation | -0.04 | 0.36 | 1.79 | 2.81 | 6.04 | Upgrade
|
| Other Operating Activities | 4.59 | 4.87 | 3.66 | -2.31 | -11.57 | Upgrade
|
| Change in Accounts Receivable | -7.69 | 18.27 | -14.06 | 18.99 | -6.36 | Upgrade
|
| Change in Inventory | 14.4 | -13.58 | 32.18 | -14.84 | 17.36 | Upgrade
|
| Change in Accounts Payable | -0.9 | 4.76 | -19.3 | 17.86 | -12.41 | Upgrade
|
| Change in Unearned Revenue | - | -0.23 | -2.17 | 2.4 | - | Upgrade
|
| Change in Other Net Operating Assets | -6.2 | 7.78 | 14.05 | 12.65 | -1.15 | Upgrade
|
| Operating Cash Flow | 16.65 | 47.55 | 6.51 | 19.71 | -44.25 | Upgrade
|
| Operating Cash Flow Growth | -65.00% | 630.92% | -66.98% | - | - | Upgrade
|
| Capital Expenditures | -37.69 | -30.24 | -18.87 | -19.99 | -332.09 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.02 | 0.04 | 0.75 | 0.05 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -0.08 | - | -0.16 | - | Upgrade
|
| Investment in Securities | 22.92 | -2 | -12.55 | 32.89 | -21.82 | Upgrade
|
| Other Investing Activities | 0.33 | 0.81 | -1.22 | 0.18 | -28.83 | Upgrade
|
| Investing Cash Flow | -14.42 | -31.48 | -31.89 | 12.96 | -382.75 | Upgrade
|
| Short-Term Debt Issued | 226.1 | 238.56 | 457.08 | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | 40 | 59.45 | 621.57 | Upgrade
|
| Total Debt Issued | 226.1 | 238.56 | 497.08 | 59.45 | 621.57 | Upgrade
|
| Short-Term Debt Repaid | -288.1 | -240.56 | -460.08 | -66 | -46.5 | Upgrade
|
| Long-Term Debt Repaid | -32.07 | -103.2 | -68.04 | -113.9 | -225.53 | Upgrade
|
| Total Debt Repaid | -320.17 | -343.76 | -528.12 | -179.9 | -272.03 | Upgrade
|
| Net Debt Issued (Repaid) | -94.07 | -105.2 | -31.04 | -120.45 | 349.54 | Upgrade
|
| Issuance of Common Stock | - | - | 279.6 | 86.3 | 13.2 | Upgrade
|
| Common Dividends Paid | -28.78 | -34.55 | -39.71 | - | -6.03 | Upgrade
|
| Financing Cash Flow | -122.84 | -139.75 | 208.86 | -34.15 | 356.71 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.8 | -2.73 | 1.34 | -0.47 | 1.82 | Upgrade
|
| Net Cash Flow | -121.42 | -126.4 | 184.81 | -1.96 | -68.47 | Upgrade
|
| Free Cash Flow | -21.04 | 17.32 | -12.37 | -0.29 | -376.35 | Upgrade
|
| Free Cash Flow Margin | -6.80% | 5.13% | -3.22% | -0.07% | -79.97% | Upgrade
|
| Free Cash Flow Per Share | -0.29 | 0.24 | -0.23 | -0.01 | -11.59 | Upgrade
|
| Cash Interest Paid | 3.12 | 4.03 | 5.08 | 3.1 | 3.62 | Upgrade
|
| Cash Income Tax Paid | 0.14 | 0.39 | 0.38 | 0.1 | 3.21 | Upgrade
|
| Levered Free Cash Flow | 263.76 | 8.9 | -300.23 | 37.17 | -371.56 | Upgrade
|
| Unlevered Free Cash Flow | 265.68 | 12.15 | -295.08 | 41.28 | -368.7 | Upgrade
|
| Change in Working Capital | -0.4 | 16.99 | 10.7 | 37.06 | -2.55 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.